Royal Bank of Canada’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $90K | Buy |
|
|||||
|
2024
Q3 | $151K | Buy |
|
|||||
|
2024
Q2 | $73K | Sell |
|
|||||
|
2024
Q1 | $467K | Buy |
|
|||||
|
2023
Q4 | $786K | Buy |
|
|||||
|
2023
Q3 | $830K | Buy |
|
|||||
|
2023
Q2 | $1.08M | Sell |
|
|||||
|
2023
Q1 | $1.41M | Sell |
|
|||||
|
2022
Q4 | $1.18M | Buy |
|
|||||
|
2022
Q3 | $1.41M | Sell |
|
|||||
|
2022
Q2 | $1.01M | Buy |
|
|||||
|
2022
Q1 | $1.1M | Sell |
|
|||||
|
2021
Q4 | $928K | Buy |
|
|||||
|
2021
Q3 | $1.16M | Buy |
|
|||||
|
2021
Q2 | $730K | Sell |
|
|||||
|
2021
Q1 | $824K | Sell |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $636K | Buy |
|
|||||
|
2020
Q2 | $592K | Buy |
|
|||||
|
2020
Q1 | $358K | Sell |
|
|||||
|
2019
Q4 | $395K | Sell |
|
|||||
|
2019
Q3 | $404K | Sell |
|
|||||
|
2019
Q2 | $412K | Buy |
|
|||||
|
2019
Q1 | $422K | Buy |
|
|||||
|
2018
Q4 | $488K | Sell |
|
|||||
|
2018
Q3 | $640K | Buy |
|
|||||
|
2018
Q2 | $704K | Sell |
|
|||||
|
2018
Q1 | $816K | Buy |
|
|||||
|
2017
Q4 | $916K | Sell |
|
|||||
|
2017
Q3 | $753K | Buy |
|
|||||
|
2017
Q2 | $627K | Buy |
|
|||||
|
2017
Q1 | $419K | Sell |
|
|||||
|
2016
Q4 | $429K | Buy |
|
|||||
|
2016
Q3 | $317K | Buy |
|
|||||
|
2016
Q2 | $261K | Sell |
|
|||||
|
2016
Q1 | $353K | Buy |
|
|||||
|
2015
Q4 | $214K | Buy |
|
|||||
|
2015
Q3 | $41K | Sell |
|
|||||
|
2015
Q2 | $57K | Buy |
|
|||||
|
2015
Q1 | $13K | Sell |
|
|||||
|
2014
Q4 | $15K | Buy |
|
|||||
|
2014
Q3 | $13K | Sell |
|
|||||
|
2014
Q2 | $888K | Buy |
|
|||||
|
2014
Q1 | $353K | Buy |
|